Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Monthly Communication Reports in: September 2024

Other options for searching the Registry: 12-Month Lobbying Activity Search; Advanced Registry Search; Recent Registrations; and Recent Monthly Communication Reports.

The list below is sorted by communication date, beginning with the most recent.

Novartis Pharmaceuticals Canada Inc.

Mark Vineis, Country President (Corporation)

Results 1-5 of 5

  • Novartis Pharmaceuticals Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)

    Subject Matter of the communication: Health, Industry
    Communication date: 2024-09-26
    Posted date: 2024-10-15
    Communication number: 15599-616359 View monthly communication report
  • Novartis Pharmaceuticals Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Aaron Wudrick, Director of Policy | Office of the Official Opposition | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2024-09-26
    Posted date: 2024-10-15
    Communication number: 15599-616360 View monthly communication report
  • Novartis Pharmaceuticals Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Valerie Bradford, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2024-09-24
    Posted date: 2024-10-15
    Communication number: 15599-616358 View monthly communication report
  • Novartis Pharmaceuticals Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Peter Fragiskatos, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2024-09-23
    Posted date: 2024-10-15
    Communication number: 15599-616357 View monthly communication report
  • Novartis Pharmaceuticals Canada Inc.
    In-house Corporation
    Designated Public Office Holders who participated in the communication:
    • Matt Jeneroux, Member of Parliament | House of Commons

    Subject Matter of the communication: Health, Industry
    Communication date: 2024-09-23
    Posted date: 2024-10-15
    Communication number: 15599-616356 View monthly communication report

Return to Monthly Communication Reports by Reporting Period

Date Modified: